The cardiac impact of cisplatin-based chemotherapy in survivors of testicular cancer: a 30-year follow-up

AIMS: Cisplatin-based chemotherapy (CBCT) is essential in the treatment of metastatic testicular cancer (TC) but has been associated with long-term risk of cardiovascular morbidity and mortality. Furthermore, cisplatin can be detected in the body decades after treatment. We aimed to evaluate the lon...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur Heart J Cardiovasc Imaging
Autors principals: Bjerring, Anders W, Fosså, Sophie D, Haugnes, Hege S, Nome, Ragnhild, Stokke, Thomas M, Haugaa, Kristina H, Kiserud, Cecilie E, Edvardsen, Thor, Sarvari, Sebastian I
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2020
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7984731/
https://ncbi.nlm.nih.gov/pubmed/33152065
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ehjci/jeaa289
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars